Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2 USD | 0,00 % | -9,50 % | +56,25 % |
Métier
Nombre d'employés: 30
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04/01/16 |
Preston Klassen
PSD | President | 55 | 22/06/23 |
Crispina Calsada
DFI | Director of Finance/CFO | 54 | 30/08/19 |
Rekha Garg
CTO | Chief Tech/Sci/R&D Officer | - | 29/11/22 |
Chief Tech/Sci/R&D Officer | - | 29/11/22 | |
Amin Kamel
PRN | Corporate Officer/Principal | - | 02/06/22 |
Daniel Penksa
AUD | Comptroller/Controller/Auditor | 39 | 01/06/15 |
Christopher Aker
LAW | General Counsel | 63 | 19/05/11 |
Brian K. Campion
PRN | Corporate Officer/Principal | - | 01/07/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 01/06/17 |
David Baltimore
BRD | Director/Board Member | 86 | 01/01/09 |
Director/Board Member | 76 | 01/04/13 | |
Chairman | 75 | 01/01/08 | |
Jake Nunn
BRD | Director/Board Member | 53 | 11/06/19 |
Alice S. Huang
BRD | Director/Board Member | 85 | 26/01/21 |
Hugh Rosen
BRD | Director/Board Member | 65 | 02/06/16 |
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04/01/16 |
Preston Klassen
PSD | President | 55 | 22/06/23 |
Director/Board Member | 56 | 17/04/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 3 725 720 | 0 | 0 | 95,99 % |
Action B | 0 | 258 707 | 0 | 0 | |
Action C | 0 | 1 330 832 | 0 | 0 | |
Action D | 1 | 65 465 876 | 64 363 679 ( 98,32 %) | 0 | |
Action E | 0 | 256 700 | 0 | 0 |
Coordonnées société
Regulus Therapeutics, Inc.
4224 Campus Point Court Suite 210
92121, San Diego
+858 202 6300
http://www.regulusrx.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+56,25 % | 131 M | |
+9,42 % | 114 Md | |
+11,84 % | 104 Md | |
-14,15 % | 22,41 Md | |
-1,05 % | 22,28 Md | |
-5,29 % | 19,07 Md | |
-38,29 % | 18 Md | |
-4,16 % | 17,89 Md | |
+7,99 % | 14,28 Md | |
+36,24 % | 12,55 Md |
- Bourse
- Actions
- Action RGLS
- Société Regulus Therapeutics Inc.